Streetbeat News

Products Services

YUMC

Yum China is focusing on product innovation to provide 'emotional value' to customers as Chinese consumers become more cautious with spending due to economic challenges.

Portfolio Pulse from

November 21, 2024 | 9:00 am

EEMMF

E3 Lithium has secured a strategic site in Alberta for its first lithium production facility, marking a significant step in its Clearwater Project. The site offers essential infrastructure to support the development.

Portfolio Pulse from

November 21, 2024 | 8:30 am

GMGI

Meridianbet, part of Golden Matrix Group Inc. (NASDAQ: GMGI), has entered a strategic partnership with Euroleague basketball team Crvena Zvezda, marking Europe's first emblem integration deal in sports sponsorship.

Portfolio Pulse from

November 21, 2024 | 8:30 am

NVS

Novartis' CEO announced that the launch of the blood-cancer drug pelabresib, acquired from Morphosys, could be delayed until 2027 or later, pending further safety data.

Portfolio Pulse from

November 21, 2024 | 8:30 am

GOOG

US prosecutors are urging Google to divest its Chrome browser and share data to dismantle its search monopoly.

Portfolio Pulse from

November 21, 2024 | 8:30 am

CTLHF

CleanTech Lithium PLC has achieved a significant milestone by successfully producing pilot-scale lithium carbonate using direct lithium extraction technology. This positions the company as a leader in this innovative technology at the pilot scale.

Portfolio Pulse from

November 21, 2024 | 8:15 am

CLVT

BioWorld by Clarivate has launched a new series highlighting gaps in women's health research and investment. The series aims to address disparities in care, funding, and innovation affecting women globally.

Portfolio Pulse from

November 21, 2024 | 8:15 am

YNVYF

Ynvisible Interactive Inc. is collaborating with Waypoint Transit Solutions to develop e-paper-based digital signs for public transportation in the US. This initiative aims to provide cost-effective, real-time transit information to cities and agencies.

Portfolio Pulse from

November 21, 2024 | 8:15 am

SHIEF

Shield Therapeutics reports strong sales of its iron deficiency drug ACCRUFeR, with a price increase boosting revenues. The company is on track to meet its 2024 revenue target of $31.5 million, as required by its debt agreement with SWK Funding.

Portfolio Pulse from

November 21, 2024 | 8:00 am